Blogs
The Lead
Risk Versus Reward
March 18, 2013 | by Michael Auerbach, Editor in Chief | Comments
Recently released reports on some currently marketed drugs have lead me to wonder if the old adage – that the treatment is worse than the disease – should be used more frequently when talking about the pharmaceutical industry - and with a “no pun intended” meaning
Congress, FDA Should Look to Existing Technology to Make Pharmacy Compounding Safer
March 5, 2013 10:21 am | by Niels Erik Hansen, Ph.D. | Comments
Last fall’s deadly meningitis outbreak linked to contaminated steroid injections is a tragic...
Seeing Both Sides
January 25, 2013 3:13 pm | by Mike Auerbach, Editor In Chief | Comments
The late, great Yankees player and coach Billy Martin was not known for holding his tongue....
A New Year’s Project with Larry the Robot
January 4, 2013 8:52 am | by Jonnatha Mayberry, Associate Editor | CommentsAnother year has begun, and while I may struggle with my own healthful resolutions, I admire the...
FREE Daily Email Newsletter
Healthcare Privacy and the Cloud
May 20, 2013 12:12 pm | by Nilesh Chandra, PA Consulting Group | CommentsCloud technology is rapidly emerging as a cost effective alternative for IT by offering scalable, robust solutions for computing, often at a fraction of the cost of more traditional software. Given the increasing adoption of technology in healthcare and rapidly growing needs for data storage and analytics, cloud technology seems ideally suited to meet many of the needs of the industry.
Is Anyone Listening?
April 18, 2013 8:21 am | by Michael Auerbach, Editor in Chief | CommentsLet’s face it – when you were growing up – perhaps mostly in your teen years – you never really listened to your parents. You might have pretended to, or developed that uncanny ability to not really listen – yet be able to recite the last sentence of whatever was said. A great skill indeed.
No Facilities – No Pharmaceuticals
February 4, 2013 3:36 pm | by Mike Auerbach, Editor in Chief, Pharmaceutical Processing | CommentsWe have all seen the bumper stickers that read: “No Farms, No Food”. I think the sentiment is pretty clear – the food that makes it to our tables doesn’t magically appear – it takes a long process that ultimately starts at a farm somewhere. I was thinking about how this relates to the pharmaceutical industry and came up with a similar slogan
Can Falsified Medicine and Other Directives Backfire?
January 31, 2013 5:48 am | by Girish Malhotra, PE, President, EPCOT International | CommentsAll of us who are concerned with pharmaceuticals have to follow and comply with different regulations and directives. In the last ten years number of do’s and don’ts and “how to” have increased. Competition for drugs and APIs from developing countries has increased.
Government of India’s Brand vs. Generic Drugs Tell of Today’s Conflicts and Reality
November 20, 2012 8:30 am | by Girish Malhotra, PE, EPCOT International | CommentsOn October 12, 2012 Government of India issued directions that drugs will be sold under their generic name rather than their brand names. This definitely caused an uproar in the drug manufacturing communities in India as evident by opinions and suggestion of legal action by different lobbying groups.
Improving Global Affordability of HIV and AIDS Drugs Through Technology Innovation
October 22, 2012 4:22 am | by Girish Malhotra, PE, President, EPCOT International | CommentsAffordability of HIV/AIDS drugs is critical for the well-being and survival of patients especially in the underdeveloped countries.
Patents: Should We Change Our Intellectual Property Model and Strategies?
October 9, 2012 4:24 am | by Girish Malhotra, PE EPCOT International | CommentsI s it time to re-visit IP strategies to make sure we are not giving away the store?
Reality in Real Time
September 25, 2012 10:11 am | by Mike Auerbach, Editor In Chief | CommentsHere’s my proposal – force all television reality shows to be done in real time and here are my reasons why this will ultimately help the pharmaceutical industry.
Fountain of Youth?
September 20, 2012 9:28 am | by Jonnatha Mayberry, Associate Editor | CommentsWe’re all getting older, whether we like it or not. But if you could fight aging from the inside out, would you?
Don't Mess With My Pet
September 19, 2012 10:42 am | by Mike Auerbach, Editor In Chief | CommentsChina's economy is growing - but can its quality control systems keep up?
Are Savings of $120-$150B Worth Having?
September 6, 2012 4:20 am | by Girish Malhotra, PE, President, EPCOT International | CommentsIn recent blogs (1,2) I had discussed ways to financially justify QbD for the pharmaceuticals. However it is up to us (everyone involved with the development and manufacture of the pharmaceuticals) to carry out the task.
When Big Pharma Pays to Stall the Introduction of Generic Drugs, Is It Legal?
August 29, 2012 8:22 am | by Thomas Carey, Partner, Sunstein Kann Murphy & Timbers LLP | CommentsThe Federal Trade Commission has long held that brand-name pharmaceutical companies may not pay generic-drug companies to stay out of the market.
The Human Touch
August 21, 2012 4:27 am | by Mike Auerbach, Editor In Chief | CommentsThroughout my travels visiting pharmaceutical companies around the country, one issue always crops up – how to stop contamination.
Is Continuous Processing in Pharma’s Future?
July 25, 2012 4:53 am | by Girish Malhotra, PE, EPCOT International | CommentsThe answer to the question is “Maybe and depends”. This is not the answer everyone would be expecting from anyone who is a proponent of “continuous processing”.
Fake It till We Make a Change
July 19, 2012 9:13 am | by Jonnatha Mayberry, Associate Editor | CommentsThe current counterfeit drug crisis is nothing short of an epidemic. And, although this epidemic doesn’t seem to be growing, it doesn’t seem to be slowing either.
